A phase 3 clinical trial involving 531 people living along the China-Myanmar border has shown that the antimalarial-antibacterial drug combination naphthoquine-azithromycin (NQAZ) is effective in preventing malarial Plasmodium infections.
Officials reported five more illnesses and three more deaths in a new Ebola outbreak in the Democratic Republic of the Congo (DRC), according to figures reported today by the country's multisectoral Ebola response committee (CMRE).
The new developments raise the outbreak total to 17 cases, 14 of them confirmed and 3 listed as probable. The new deaths raise the fatality count to 11.
A study yesterday in the Annals of Internal Medicine of more than 2,000 Europeans diagnosed as having mild to moderate COVID-19 shows that 87% reported loss of smell, and 56% reported taste dysfunction. The study suggests olfactory symptoms and taste disorders may be a common feature of COVID-19 infection.
A white paper published today in Infection Control and Hospital Epidemiology calls on antibiotic stewardship programs (ASPs) to take steps to address the potential legal implications of stewardship activities.
An international team of experts has published guidelines in CMAJ on treating COVID-19 patients that include "weak" recommendations for using corticosteroids in patients with acute respiratory distress syndrome (ARDS) and against using corticosteroids for patients without ARDS, convalescent plasma in patients with severe disease, and antiviral drugs in general.
The arm of a trial involving high-dose chloroquine had to be stopped early.
The Centers for Disease Control and Prevention (CDC) said in an update yesterday that it has concluded its investigation into a 10-state outbreak of Escherichia coli linked to contaminated clover sprouts that sickened 51 people, up 12 from the agency's Mar 19 update.
While laboratory-confirmed flu cases continue to decline in the United States, the number of people visiting healthcare providers for influenza-like illness (ILI) rose sharply again last week, according to the Centers for Disease Control and Prevention's (CDC's) latest FluView report today.
Analysis of six European studies on the 2019/2020 influenza season indicate the interim vaccine effectiveness (VE) against laboratory-confirmed influenza in the primary care setting ranged from 29% to 61% and from 35% to 60% in hospitalized older adults. The results appeared today in Eurosurveillance.
A study conducted in a large healthcare system in Colorado found that a multicomponent intervention was associated with increased use of first-line antibiotics among children with uncomplicated urinary tract infections (UTIs), researchers reported today in Pediatrics.